Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03WAT
|
|||
Former ID |
DIB005237
|
|||
Drug Name |
PRC-4016
|
|||
Indication | Dyslipidemia [ICD-11: 5C80-5C81; ICD-9: 272] | Phase 2 | [1] | |
Arteriosclerosis [ICD-11: BD40; ICD-10: I70] | Investigative | [2] | ||
Company |
Pronova biopharma
|
|||
Structure |
![]() |
Download2D MOL
|
||
Formula |
C24H38O3
|
|||
Canonical SMILES |
CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O
|
|||
InChI |
1S/C24H38O3/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-23(4-2)24(25)26/h5-6,8-9,11-12,14-15,17-18,23H,3-4,7,10,13,16,19-22H2,1-2H3,(H,25,26)/b6-5-,9-8-,12-11-,15-14-,18-17-
|
|||
InChIKey |
VOGXDRFFBBLZBT-AAQCHOMXSA-N
|
|||
CAS Number |
CAS 1253909-57-7
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01972178) Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia. U.S. National Institutes of Health. | |||
REF 2 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.